Bio­con Re­calls 5K Sim­vas­tatin Bot­tles in US

The Economic Times - - Companies -

Bio­con is re­call­ing in the US 5,505 bot­tles of choles­terol low­er­ing Sim­vas­tatin tablets for be­ing sub-po­tent, ac­cord­ing to the USFDA. The 5,505 bot­tles of Sim­vas­tatin tablets in the strength of 5 mg are be­ing re­called in a firm ini­ti­ated on­go­ing re­call due to the prod­uct be­ing a 'sub­po­tent drug', the United States Food and Drug Ad­min­is­tra­tion (USFDA) said in its lat­est En­force­ment Re­port. The tablets are man­u­fac­tured by Blu Caribe Do­rado for Blu Phar­ma­ceu­ti­cals Franklin, it added.


Newspapers in English

Newspapers from India

© PressReader. All rights reserved.